Total Funding
25
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
162685
ReShape Lifesciences is a developer of medical devices to treat obesity and metabolic diseases.
Acquired by 
Vyome Therapeutics
Bart Bandy: CEO and PresidentPast Role: Alphaeon, President, ALPHAEON Wellness- Dov Gal: Vice President, Regulatory and Clinical Affairs
About the Company
ReShape Lifesciences is a weight-loss solutions company that offers an integrated portfolio of proven products and services that manage and treat obesity and metabolic diseases. The FDA-approved Lap-Band System provides minimally invasive, long-term treatment of obesity. It is an alternative to more invasive surgical stapling procedures such as
gastric bypass or sleeve gastrectomy. The ReShape Vest System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It helps enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy.
